Current Market Outlook

Kalshi traders are pricing "Spider-Man: Brand New Day" at 100% to score above 55 on the Tomatometer. That is not a prediction. It is a lock. The market sees a score below 55 as virtually impossible for a major Sony/Marvel theatrical release.

For context, no live-action Spider-Man film has ever scored below 87 on Rotten Tomatoes. The lowest is "The Amazing Spider-Man 2" at 51%, but that film still sits far above the 55 threshold. Every other entry clears 85% easily. "Spider-Man: No Way Home" sits at 93%. "Spider-Man: Across the Spider-Verse" hit 95%.

This contract is essentially free money at current prices. The real action will come when Kalshi lists higher strike values, likely 70, 80, or 90.

Key Factors Driving the Odds

The 100% pricing reflects franchise history more than specific knowledge of "Brand New Day." Sony has not released a Spider-Man film that critics hated in over a decade. Even the weaker entries like "The Amazing Spider-Man" (72%) and "Venom" (30%) are irrelevant here because this contract requires only 55.

The film brings back Tom Holland, Zendaya, and director Destin Daniel Cretton, who directed "Shang-Chi" (91%). That pedigree alone makes a 55 score a floor, not a ceiling. Critics grade these films on a superhero curve, but the floor is high.

What Could Change These Odds

Nothing can change this specific contract. It will resolve Yes. The only risk is if the film gets cancelled or delayed past August 3, 2026. Even a catastrophic release would need to score below 55 to hit No, which means a film worse than "Morbius" (16%) or "Madame Web" (11%). Sony would have to intentionally make a bad movie to lose this bet.

Traders should look for higher-strike contracts. A 70+ market would trade around 85-90 cents. An 80+ market would be the real test, pricing near 70-75 cents based on the franchise average.